IL128532A0 - Method of treating impotence due to spinal cord injury - Google Patents

Method of treating impotence due to spinal cord injury

Info

Publication number
IL128532A0
IL128532A0 IL12853299A IL12853299A IL128532A0 IL 128532 A0 IL128532 A0 IL 128532A0 IL 12853299 A IL12853299 A IL 12853299A IL 12853299 A IL12853299 A IL 12853299A IL 128532 A0 IL128532 A0 IL 128532A0
Authority
IL
Israel
Prior art keywords
spinal cord
cord injury
impotence due
treating impotence
male
Prior art date
Application number
IL12853299A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of IL128532A0 publication Critical patent/IL128532A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Electrotherapy Devices (AREA)
IL12853299A 1998-02-23 1999-02-15 Method of treating impotence due to spinal cord injury IL128532A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7558098P 1998-02-23 1998-02-23

Publications (1)

Publication Number Publication Date
IL128532A0 true IL128532A0 (en) 2000-01-31

Family

ID=22126701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12853299A IL128532A0 (en) 1998-02-23 1999-02-15 Method of treating impotence due to spinal cord injury

Country Status (17)

Country Link
US (1) US20060040935A1 (de)
EP (1) EP0951908B1 (de)
JP (1) JPH11315025A (de)
KR (1) KR19990072798A (de)
AT (1) ATE279194T1 (de)
AU (1) AU755402B2 (de)
CA (1) CA2262268C (de)
DE (1) DE69921008T2 (de)
DK (1) DK0951908T3 (de)
ES (1) ES2226281T3 (de)
HU (1) HUP9900438A3 (de)
IL (1) IL128532A0 (de)
MY (1) MY133446A (de)
NZ (1) NZ334333A (de)
PT (1) PT951908E (de)
TW (1) TW542719B (de)
ZA (1) ZA991393B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
US6613768B1 (en) 1999-04-30 2003-09-02 Lilly Icos Llc Treatment of female arousal disorder
MXPA02006240A (es) 1999-12-24 2003-01-28 Bayer Ag Nuevas imidazo[1,3,5,) triazinonas y su uso.
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
KR100393160B1 (ko) * 2001-06-14 2003-07-31 한국과학기술연구원 신규한 피라졸로피리미딘티온 유도체, 그의 제법 및발기부전 치료제로서의 용도
EP1404336A1 (de) * 2001-06-14 2004-04-07 Sampad Bhattacharya Zusammensetzungen enthaltend cgmp-pde5-hemmar zur transdermalen verabreichung zur erektilgewebe des penises
EP1750766B1 (de) * 2004-05-11 2013-07-03 Emotional Brain B.V. Pharmazeutische Formulierungen und ihre Verwendungen bei der Behandlung von weiblicher sexueller Dysfunktion
EP1790343A1 (de) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmazeutische Zusammensetzungen und deren Verwendung zur Behandlung sexueller Störungen der Frau
EP1925307A1 (de) * 2006-11-03 2008-05-28 Emotional Brain B.V. Verwendung von 3-alpha-androstanediol zur Behandlung sexueller Dysfunktion
WO2008142396A1 (en) * 2007-05-18 2008-11-27 Anthony Denis Maher Methods of assessing male fertility using a uridine marker

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HU9900438D0 (en) 1999-04-28
DE69921008T2 (de) 2006-02-02
EP0951908A2 (de) 1999-10-27
PT951908E (pt) 2005-01-31
DE69921008D1 (de) 2004-11-18
ATE279194T1 (de) 2004-10-15
AU1839099A (en) 1999-09-09
NZ334333A (en) 2000-11-24
EP0951908A3 (de) 2000-08-16
ZA991393B (en) 2000-08-22
AU755402B2 (en) 2002-12-12
DK0951908T3 (da) 2004-12-27
TW542719B (en) 2003-07-21
US20060040935A1 (en) 2006-02-23
EP0951908B1 (de) 2004-10-13
CA2262268A1 (en) 1999-08-23
KR19990072798A (ko) 1999-09-27
HUP9900438A3 (en) 2002-01-28
ES2226281T3 (es) 2005-03-16
CA2262268C (en) 2003-07-29
HUP9900438A2 (hu) 2000-03-28
MY133446A (en) 2007-11-30
JPH11315025A (ja) 1999-11-16

Similar Documents

Publication Publication Date Title
IL128532A0 (en) Method of treating impotence due to spinal cord injury
MY117967A (en) Intranasal formulations for treating sexual disorders
ZA200206612B (en) Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction.
EP1005336A4 (de) Verbesserte verfahren und zusammensetzungen zur behandlung männlicher erektionsstörungen
WO1994004120A3 (en) Methods of treating sexual dysfunction in animals with and h agonist
GC0000096A (en) Treatment of female sexual dysfunction.
PL343794A1 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
ZA914135B (en) Method of treating impotence
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
ID24184A (id) Obat untuk perawatan disfungsi ereksi
AU2623700A (en) Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
WO2000053148A3 (en) Methods and compositions for treating erectile dysfunction
WO2005051368A3 (en) Phosphodiesterase v inhibitor formulations
MD1979F1 (en) Method of secondary cataract treatment
IL166273A0 (en) Methods of treatment of male erectile dysfunction
GR3021677T3 (en) Use of atipamezole for the treatment of male sexual impotence
AU2001281396A1 (en) Novel compositions and methods for treatment of male erectile dysfunction
CA2203379A1 (en) Cgmp-pde inhibitors for the treatment of erectile dysfunction
GB0030647D0 (en) Treatment of male sexual dysfunction
HK1089661A (en) Methods for the treatment of male and female sexual dysfunction
ZA992793B (en) Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction.
ECSP993027A (es) Formulaciones intranasales para trastornos sexuales
AU2002300695A1 (en) Treatments for Female Sexual Dysfunction and Methods for Identifying Compounds Useful for Treating Female Sexual Dysfunction
HK1028562A (en) Improved methods and compositions for treating male erectile dysfunction
GEP20043347B (en) Use of Pyrazolopyrimidinones for Treatment of Impotence

Legal Events

Date Code Title Description
HP Change in proprietorship